0000899243-18-020525.txt : 20180724 0000899243-18-020525.hdr.sgml : 20180724 20180724175247 ACCESSION NUMBER: 0000899243-18-020525 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180718 FILED AS OF DATE: 20180724 DATE AS OF CHANGE: 20180724 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Pillar Invest Corp CENTRAL INDEX KEY: 0001534428 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31918 FILM NUMBER: 18967248 BUSINESS ADDRESS: STREET 1: C/O PILLAR INVEST OFFSHORE SAL STREET 2: STARCO CENTER, BLOC B FL3, OMAR DAOUK ST CITY: BEIRUT STATE: M8 ZIP: 2020-3313 BUSINESS PHONE: 0119611363362 MAIL ADDRESS: STREET 1: C/O PILLAR INVEST OFFSHORE SAL STREET 2: STARCO CENTER, BLOC B FL3, OMAR DAOUK ST CITY: BEIRUT STATE: M8 ZIP: 2020-3313 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Pillar Pharmaceuticals II, L.P. CENTRAL INDEX KEY: 0001562069 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31918 FILM NUMBER: 18967249 BUSINESS ADDRESS: STREET 1: STARCO CENTER BLOC B, THIRD FLOOR STREET 2: OMAR DAOUK STREET CITY: BEIRUT 2020-3313 STATE: M8 ZIP: 2020-3313 BUSINESS PHONE: 9611363362 MAIL ADDRESS: STREET 1: STARCO CENTER BLOC B, THIRD FLOOR STREET 2: OMAR DAOUK STREET CITY: BEIRUT 2020-3313 STATE: M8 ZIP: 2020-3313 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IDERA PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0000861838 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 043072298 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 167 SIDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 6176795500 MAIL ADDRESS: STREET 1: 167 SIDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 FORMER COMPANY: FORMER CONFORMED NAME: HYBRIDON INC DATE OF NAME CHANGE: 19951211 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-07-18 0 0000861838 IDERA PHARMACEUTICALS, INC. IDRA 0001534428 Pillar Invest Corp C/O IDERA PHARMACEUTICALS, INC. 167 SIDNEY STREET CAMBRIDGE MA 02139 0 0 1 0 0001562069 Pillar Pharmaceuticals II, L.P. PILLAR INVEST OFFSHORE SAL, STARCO CTR, BLOC B, 3RD FLOOR, OMAR DAOUK STREET BEIRUT M8 2020-3313 LEBANON 0 0 1 0 Common Stock 2018-07-18 4 S 0 1725000 0.8524 D 0 I See Footnote Common Stock 2018-07-19 4 S 0 556000 0.8804 D 0 I See Footnote Common Stock 2018-07-20 4 S 0 492567 0.8581 D 0 I See Footnote The shares sold on this date were sold in multiple transactions. This price is the weighted average sales price per share of all shares sold on this date; the actual sale prices per share range from $0.8006-$0.9204. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Shares sold by Pillar Pharmaceuticals II, L.P. ("Pillar II"). Pillar GP disclaims Section 16 beneficial ownership of the securities beneficially owned by Pillar II and this report shall not be deemed an admission that Pillar GP is the Section 16 beneficial owner of any such securities, except to the extent of its pecuniary interest therein, if any, by virtue of its ownership interest in Pillar II. Following this transaction, Pillar II owns directly 7,360,451 shares of common stock of the Issuer. The shares sold on this date were sold in multiple transactions. This price is the weighted average sales price per share of all shares sold on this date; the actual sale prices per share range from $0.8340-$0.9234. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Shares sold by Pillar II. Pillar GP disclaims Section 16 beneficial ownership of the securities beneficially owned by Pillar II and this report shall not be deemed an admission that Pillar GP is the Section 16 beneficial owner of any such securities, except to the extent of its pecuniary interest therein, if any, by virtue of its ownership interest in Pillar II. Following this transaction, Pillar II owns directly 6,804,451 shares of common stock of the Issuer. The shares sold on this date were sold in multiple transactions. This price is the weighted average sales price per share of all shares sold on this date; the actual sale prices per share range from $0.8300-$0.8818. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Shares sold by Pillar II, of which Pillar GP is the general partner. Pillar GP disclaims Section 16 beneficial ownership of the securities beneficially owned by Pillar II and this report shall not be deemed an admission that Pillar GP is the Section 16 beneficial owner of any such securities, except to the extent of its pecuniary interest therein, if any, by virtue of its ownership interest in Pillar II. Following this transaction, Pillar II owns directly 6,311,884 shares of common stock of the Issuer. Pillar Invest Corporation, /s/ Youssef El Zein, Authorized Person 2018-07-24